Cargando…
MicroRNA-1 inhibits tumorigenicity of esophageal squamous cell carcinoma and enhances sensitivity to gefitinib
Dysregulation of microRNAs in various types of human cancer promote or suppress oncogenesis. MicroRNA (miR)-1 was previously revealed to function as a tumor suppressor in prostate cancer cells, and its expression was associated with reduced metastatic potential in lung cancer. The present study inve...
Autores principales: | Yu, Qianqian, Liu, Yiqian, Wen, Chengcai, Zhao, Yongzhao, Jin, Shidai, Hu, Youfang, Wang, Feng, Chen, Liang, Zhang, Bin, Wang, Wei, Zhu, Quan, Guo, Renhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772756/ https://www.ncbi.nlm.nih.gov/pubmed/29399158 http://dx.doi.org/10.3892/ol.2017.7378 |
Ejemplares similares
-
Axl-altered microRNAs regulate tumorigenicity and gefitinib resistance in lung cancer
por: Wang, Y, et al.
Publicado: (2014) -
MiR‐873 inhibition enhances gefitinib resistance in non‐small cell lung cancer cells by targeting glioma‐associated oncogene homolog 1
por: Jin, Shidai, et al.
Publicado: (2018) -
LINC00665 Induces Acquired Resistance to Gefitinib through Recruiting EZH2 and Activating PI3K/AKT Pathway in NSCLC
por: Liu, Xinyin, et al.
Publicado: (2019) -
Pemetrexed induces ROS generation and cellular senescence by attenuating TS‐mediated thymidylate metabolism to reverse gefitinib resistance in NSCLC
por: Chen, Yun, et al.
Publicado: (2023) -
MicroRNA-30e reduces cell growth and enhances drug sensitivity to gefitinib in lung carcinoma
por: Ning, Zhi-Qiang, et al.
Publicado: (2016)